Stake Purchase • Life Science

Ranbaxy Laboratories Invests In Zenotech Laboratories

On October 3, 2007, Ranbaxy Laboratories invested in life science company Zenotech Laboratories

Investment Context
  • This is Ranbaxy Laboratories’ 2nd transaction in the Life Science sector.
  • This is Ranbaxy Laboratories’ 1st transaction in India.

Explore All 282 Stake Purchase Life Science Deals - Search the Database Free


Investment Summary

Date October 3, 2007
Target Zenotech Laboratories
Sector Life Science
Investor(s) Ranbaxy Laboratories
Deal Type Stake Purchase

Target Company

Zenotech Laboratories

Hyderabad, India
Zenotech Laboratories Limited, a pharmaceutical specialty generic injectables company, manufactures bio-technology products.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

Ranbaxy Laboratories

New Delhi, India

Category Company
Founded 1961
Sector Life Science
Employees15,300
DESCRIPTION

Ranbaxy Limited is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy’s continued focus on R&D has resulted in several approvals in developed and emerging 4 markets, many of which incorporate proprietary Novel Drug Delivery Systems and technologies developed at its own labs.


Deal Context for Investor #
Overall 2 of 2
Sector: Life Science 2 of 2
Type: Stake Purchase 1 of 1
Country: India 1 of 1
Year: 2007 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-03-29 Terapia SA

Cluj-Napoca, Romania

Terapia, then second-largest pharmaceuticals manufacturer in Romania, was a household name with an 80-year heritage.

Buy $324M

Explore Related M&A Activity